Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects
Public ClinicalTrials.gov record NCT06063330. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Multicenter, Randomized, Double-blind, Placebo- Controlled, Parallel Group Study to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects
Study identification
- NCT ID
- NCT06063330
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Red Queen Therapeutics, Inc.
- Industry
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Interventions
- RQ-001 Combination Product
- Placebo Other
Combination Product · Other
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 26, 2023
- Primary completion
- Jan 2, 2024
- Completion
- Jan 2, 2024
- Last update posted
- Jan 10, 2024
2023 – 2024
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| LA Universal Research Center, Inc. | Los Angeles | California | 90057 | — |
| Florida International Medical Research | Miami | Florida | 33134 | — |
| University of Maryland School of Medicine | Baltimore | Maryland | 21201 | — |
| Zenos Clinical Research | Dallas | Texas | 75230 | — |
| Vilo Research Group, L.L.C. | Houston | Texas | 77017 | — |
| Evergreen Hospital Medical Center | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06063330, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 10, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06063330 live on ClinicalTrials.gov.